These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1663439)

  • 21. Trends in the management of childhood lead poisonings.
    Rosen JF; Markowitz ME
    Neurotoxicology; 1993; 14(2-3):211-7. PubMed ID: 8247394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quercetin administration during chelation therapy protects arsenic-induced oxidative stress in mice.
    Mishra D; Flora SJ
    Biol Trace Elem Res; 2008 May; 122(2):137-47. PubMed ID: 18183357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Succimer and the reduction of tissue lead in juvenile monkeys.
    Smith DR; Woolard D; Luck ML; Laughlin NK
    Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [2,3-dimercaptosuccinic acid: a new chelating agent, safe and efficacious, for lead poisoning].
    Nogué S; Sanz-Gallén P; Munné P; To-Figueras J
    Med Clin (Barc); 1993 Oct; 101(12):478-9. PubMed ID: 8231377
    [No Abstract]   [Full Text] [Related]  

  • 26. Chelation therapy in children exposed to lead.
    Shannon M; Woolf A; Binns H
    N Engl J Med; 2001 Oct; 345(16):1212-3. PubMed ID: 11642245
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dL. Treatment of Lead-Exposed Children (TLC) Trial Group.
    Pediatr Res; 2000 Nov; 48(5):593-9. PubMed ID: 11044477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lead poisoning following administration of "home specialties"].
    Voack C; Kayasseh L; Galeazzi RL
    Schweiz Med Wochenschr; 1993 Nov; 123(46):2198-210. PubMed ID: 8272790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
    Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
    Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of succimer therapy in lead intoxication using postural balance as a measure: a case study in a nine year old child.
    Bhattacharya A; Smelser DT; Berger O; Shukla R; Medvedovic M
    Neurotoxicology; 1998 Feb; 19(1):57-64. PubMed ID: 9498221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral chelators for childhood lead poisoning.
    Liebelt EL; Shannon MW
    Pediatr Ann; 1994 Nov; 23(11):616-9, 623-6. PubMed ID: 7838614
    [No Abstract]   [Full Text] [Related]  

  • 32. The impact of succimer chelation on blood cadmium in children with background exposures: a randomized trial.
    Cao Y; Chen A; Bottai M; Caldwell KL; Rogan WJ
    J Pediatr; 2013 Aug; 163(2):598-600. PubMed ID: 23601497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The scientific basis for chelation: animal studies and lead chelation.
    Smith D; Strupp BJ
    J Med Toxicol; 2013 Dec; 9(4):326-38. PubMed ID: 24113857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of modified citrus pectin as an effective chelator of lead in children hospitalized with toxic lead levels.
    Zhao ZY; Liang L; Fan X; Yu Z; Hotchkiss AT; Wilk BJ; Eliaz I
    Altern Ther Health Med; 2008; 14(4):34-8. PubMed ID: 18616067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
    Tantanasrikul S; Chaivisuth B; Siriratanapreuk S; Padungtod C; Pleubreukan R; Boonnark T; Worahan S; Bhumiratanarak P; Chomchai C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deaths associated with hypocalcemia from chelation therapy--Texas, Pennsylvania, and Oregon, 2003-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(8):204-7. PubMed ID: 16511441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Succimer--an oral drug for lead poisoning.
    Med Lett Drugs Ther; 1991 Aug; 33(850):78. PubMed ID: 1649375
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of chronic lead toxicity with succimer: a case series of 2 adults with retained lead shotgun fragments.
    Cyrus RM; Woller SC; Stevens MH; Pugh MR; Stevens SM; Edwards CQ
    Am J Forensic Med Pathol; 2011 Sep; 32(3):236-8. PubMed ID: 21512379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary prevention of childhood lead poisoning--the only solution.
    Rosen JF; Mushak P
    N Engl J Med; 2001 May; 344(19):1470-1. PubMed ID: 11346814
    [No Abstract]   [Full Text] [Related]  

  • 40. DMSA.
    Altern Med Rev; 2000 Jun; 5(3):264-7. PubMed ID: 10869106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.